SecBot SecBot

ASAP Act

H.R. 6130 Rep. Vern Buchanan (R-FL-16) In committee
Bill text PDF
  1. Introduced Nov 19
  2. Committee Nov 19
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Nov 19, 2025Next: House vote
42d ago Sep 16, 2026: Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
4companies, 10 filings
Subscribe to see spend
Member trades
6trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

4 companies
Companies by sector
Biotech & Pharma 3Medical Devices & Healthcare 1
Search all 4 companies, their asks and price moves Subscribe

Summary

Alzheimer's Screening and Prevention Act of 2025 or the ASAP Act

Full summary1 paragraphs

This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.

Library of Congress summary, Nov 19, 2025

Summary versions
  • Introduced in HouseNov 19, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.